User profiles for J.L. Mas

Jean-Louis Mas

Professeur de Neurologie, Université Paris Descartes; Chef de service, Hôpital Sainte-Anne; …
Verified email at ch-sainte-anne.fr
Cited by 149347

Neuroimaging in posterior reversible encephalopathy syndrome

…, C Oppenheim, JF Meder, JL Mas - Journal of …, 2004 - Wiley Online Library
The terms posterior reversible leukoencephalopathy, reversibleposterior cerebral edema
syndrome, and posterior reversibleencephalopathy syndrome(PRES) all refer to a …

Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis

…, G Chatellier, S Peyrard, PM Rothwell, JL Mas - Stroke, 2005 - Am Heart Assoc
Background— Whether stroke patients should be investigated for asymptomatic coronary
artery disease remains matter of debate. Absolute risks of myocardial infarction (MI) and …

Aetiological diagnosis of ischaemic stroke in young adults

JM Ferro, AR Massaro, JL Mas - The Lancet Neurology, 2010 - thelancet.com
Despite improvements in diagnosis and treatment, ischaemic stroke in young adults remains
a catastrophic event from the patients' perspective. Stroke can cause death, disability, and …

A reversible posterior leukoencephalopathy syndrome

…, A Wang, MS Pessin, C Lamy, JL Mas… - … England Journal of …, 1996 - Mass Medical Soc
Background and Methods In some patients who are hospitalized for acute illness, we have
noted a reversible syndrome of headache, altered mental functioning, seizures, and loss of …

[HTML][HTML] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

…, SC Johnston, KH Mak, JL Mas… - … England Journal of …, 2006 - Mass Medical Soc
Background Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been
studied in a broad population of patients at high risk for atherothrombotic events. Methods We …

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

…, PG Steg, EM Ohman, AT Hirsch, Y Ikeda, JL Mas… - Jama, 2006 - jamanetwork.com
ContextAtherothrombosis is the leading cause of cardiovascular morbidity and mortality
around the globe. To date, no single international database has characterized the …

[HTML][HTML] Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis

JL Mas, G Chatellier, B Beyssen… - … England Journal of …, 2006 - Mass Medical Soc
Background Carotid stenting is less invasive than endarterectomy, but it is unclear whether
it is as safe in patients with symptomatic carotid-artery stenosis. Methods We conducted a …

Prevalence of patent foramen ovale in patients with stroke

PH Lechat, JL Mas, G Lascault, PH Loron… - … England Journal of …, 1988 - Mass Medical Soc
The cause of ischemic stroke in younger adults is undefined in as many as 35 percent of
patients. We studied the prevalence of patent foramen ovale as detected by contrast …

One-year cardiovascular event rates in outpatients with atherothrombosis

…, EM Ohman, J Röther, CS Liau, AT Hirsch, JL Mas… - Jama, 2007 - jamanetwork.com
ContextFew data document current cardiovascular (CV) event rates in stable patients with
atherothrombosis in a community setting. Differential event rates for patients with documented …

[HTML][HTML] Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke

JL Mas, G Derumeaux, B Guillon… - … England Journal of …, 2017 - Mass Medical Soc
Background Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have
been inconclusive. We investigated whether patients with cryptogenic stroke and …